Your browser doesn't support javascript.
loading
IgA Nephropathy in Children: A Multicenter Study in Poland.
Mizerska-Wasiak, M; Turczyn, A; Such, A; Cichon-Kawa, K; Maldyk, J; Miklaszewska, M; Pietrzyk, J; Rybi-Szuminska, A; Wasilewska, A; Firszt-Adamczyk, A; Stankiewicz, R; Szczepanska, M; Bienias, B; Zajaczkowska, M; Pukajlo-Marczyk, A; Zwolinska, D; Siniewicz-Luzenczyk, K; Tkaczyk, M; Gadomska-Prokop, K; Grenda, R; Demkow, U; Panczyk-Tomaszewska, M.
Affiliation
  • Mizerska-Wasiak M; Department of Pediatrics and Nephrology, Medical University of Warsaw, 63A Zwirki i Wigury Street, 02-091, Warsaw, Poland. wasiaczki@wp.pl.
  • Turczyn A; Department of Pediatrics and Nephrology, Medical University of Warsaw, 63A Zwirki i Wigury Street, 02-091, Warsaw, Poland.
  • Such A; Department of Pediatrics and Nephrology, Medical University of Warsaw, 63A Zwirki i Wigury Street, 02-091, Warsaw, Poland.
  • Cichon-Kawa K; Department of Pediatrics and Nephrology, Medical University of Warsaw, 63A Zwirki i Wigury Street, 02-091, Warsaw, Poland.
  • Maldyk J; Department of Pathology, Medical University of Warsaw, Warsaw, Poland.
  • Miklaszewska M; Department of Pediatric Nephrology, Jagiellonian University, Cracow, Poland.
  • Pietrzyk J; Department of Pediatric Nephrology, Jagiellonian University, Cracow, Poland.
  • Rybi-Szuminska A; Department of Pediatrics and Nephrology, Medical University of Bialystok, Bialystok, Poland.
  • Wasilewska A; Department of Pediatrics and Nephrology, Medical University of Bialystok, Bialystok, Poland.
  • Firszt-Adamczyk A; Department of Pediatrics and Nephrology, Ludwik Rydygier Hospital, Torun, Poland.
  • Stankiewicz R; Department of Pediatrics and Nephrology, Ludwik Rydygier Hospital, Torun, Poland.
  • Szczepanska M; Department of Pediatrics, SMDZ in Zabrze, Silesian Medical University, Katowice, Poland.
  • Bienias B; Department of Pediatric Nephrology, Medical University of Lublin, Lublin, Poland.
  • Zajaczkowska M; Department of Pediatric Nephrology, Medical University of Lublin, Lublin, Poland.
  • Pukajlo-Marczyk A; Department of Pediatric Nephrology, Wroclaw Medical University, Wroclaw, Poland.
  • Zwolinska D; Department of Pediatric Nephrology, Wroclaw Medical University, Wroclaw, Poland.
  • Siniewicz-Luzenczyk K; Department of Pediatrics, Immunology and Nephrology, Polish Mothers Memorial Hospital Research Institute, Lodz, Poland.
  • Tkaczyk M; Department of Pediatrics, Immunology and Nephrology, Polish Mothers Memorial Hospital Research Institute, Lodz, Poland.
  • Gadomska-Prokop K; Department of Nephrology, Kidney Transplantation and Hypertension, Children's Memorial Health Institute, Warsaw, Poland.
  • Grenda R; Department of Nephrology, Kidney Transplantation and Hypertension, Children's Memorial Health Institute, Warsaw, Poland.
  • Demkow U; Department of Laboratory Diagnostics and Clinical Immunology of Developmental Age, Medical University of Warsaw, Warsaw, Poland.
  • Panczyk-Tomaszewska M; Department of Pediatrics and Nephrology, Medical University of Warsaw, 63A Zwirki i Wigury Street, 02-091, Warsaw, Poland.
Adv Exp Med Biol ; 952: 75-84, 2016.
Article in En | MEDLINE | ID: mdl-27573641
ABSTRACT
IgA nephropathy (IgAN) is the most common form of glomerulonephritis in pediatric population. The clinical presentation of the disease in children ranges from microscopic hematuria to end-stage kidney disease. The aim of the study was to retrospectively assess clinical and kidney biopsy features in children with IgAN. We assessed a cohort of 140 children, 88 boys, 52 girls with the diagnosis of IgAN in the period of 2000-2015, entered into the national Polish pediatric IgAN registry. The assessment included the following proteinuria, hematuria, glomerular filtration rate (GFR), arterial blood pressure, and the renal pathological changes according to the Oxford classification and crescents formation, as modifiable and unmodifiable risk factors. The incidence of IgAN in Poland was set at 9.3 new cases per year. The mean age at onset of IgAN was 11.9 ± 4.3 years, and the most common presentation of the disease was the nephritic syndrome, recognized in 52 % of patients. Kidney biopsy was performed, on average, 1.3 ± 2.0 years after onset of disease. Based on the ROC analysis, a cut-off age at onset of disease for GFR <90 mL/min/1.73 m2 (risk factor of progression) was calculated as 13.9 years. Unmodifiable lesions segmental sclerosis, tubular atrophy/interstitial fibrosis (S1, T1-2) in the Oxford classification and crescents in kidney biopsy were significantly more common in Gr 1 (>13.9 years) compared with Gr 2 (<13.9 years), despite a significantly shorter time to kidney biopsy in the former. We conclude that IgAN in children may be an insidious disease. A regular urine analysis, especially after respiratory tract infections, seems the best way for an early detection of the disease.
Subject(s)
Key words
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Registries / Glomerulonephritis, IGA / Kidney Type of study: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Adolescent / Child / Female / Humans / Male Country/Region as subject: Europa Language: En Journal: Adv Exp Med Biol Year: 2016 Document type: Article Affiliation country:
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Registries / Glomerulonephritis, IGA / Kidney Type of study: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Adolescent / Child / Female / Humans / Male Country/Region as subject: Europa Language: En Journal: Adv Exp Med Biol Year: 2016 Document type: Article Affiliation country:
...